Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Home › News
📰 All News

Life Science & Pharma News

The latest pharmaceutical, biotechnology, MedTech, and healthcare news and analysis from Ireland, the EU, and globally.

224
Articles
19
Pages
IE
Ireland first
Women in Pharma Awards 2026 Recognise Sector’s Outstanding Talent Across Ireland
Industry
Women in Pharma Awards 2026 Recognise Sector’s Outstanding Talent Across Ireland
20 trophies presented at gala Dublin ceremony celebrating leadership, innovation, and clinical trials excellence across Ireland's €100B+ pharmaceutical and life sciences sector.
Sreepriya Prasannan
Sreepriya Prasannan
07 Aug 2026 · 3 min
Moving from India to Ireland in 2026: The Definitive Education, Visa, Relocation, and Career Master Guide for Indian Students & Professionals
Industry
Moving from India to Ireland in 2026: The Definitive Education, Visa, Relocation, and Career Master Guide for Indian Students & Professionals
An exhaustive, 5,000+ word master guide for Indian students, life science graduates, and working professionals moving to Ireland in 2026. Covers Stamp 2 & Stamp 1G post-study work visas, CSEP permits, university selection, VFS Global India processing, PCC, financial proof, housing scam warnings, and ethical career entry into Ireland's €100B+ biopharma sector.
Sreepriya Prasannan
Sreepriya Prasannan
06 Aug 2026 · 9 min
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Industry
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Global equity markets open August 2026 on a historic high as rumored $400B AstraZeneca-BMS merger talks and Curium's $8B Lantheus acquisition spark a massive biopharmaceutical consolidation wave.
Sreepriya Prasannan
Sreepriya Prasannan
03 Aug 2026 · 3 min
Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Industry
Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
An in-depth evaluation of Donald Trump’s scheduled September visit to Ireland, examining the Doonbeg Irish Open itinerary, security logistics, protectionist tariffs, corporate tax policy friction, and strategic implications for U.S.-Irish bilateral relations.
Sreepriya Prasannan
Sreepriya Prasannan
03 Aug 2026 · 4 min
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Sreepriya Prasannan
Sreepriya Prasannan
02 Aug 2026 · 28 min
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Sreepriya Prasannan
Sreepriya Prasannan
29 Jul 2026 · 6 min
Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance
Industry
Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance
An authoritative enterprise guide for pharmaceutical professionals on using Large Language Models (LLMs) safely, mitigating hallucination and data privacy risks, ensuring GxP and EU AI Act compliance, and establishing human-in-the-loop workflows.
Sreepriya Prasannan
Sreepriya Prasannan
29 Jul 2026 · 6 min
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
Sreepriya Prasannan
Sreepriya Prasannan
29 Jul 2026 · 6 min
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
Industry
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.
Sreepriya Prasannan
Sreepriya Prasannan
29 Jul 2026 · 6 min
ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion
Industry
ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion
OpenAI secures an 88,000 sq ft lease at IPUT's iconic Tropical Fruit Warehouse on Sir John Rogerson's Quay, bringing 250 new high-tech jobs to Dublin as it expands its European headquarters.
Sreepriya Prasannan
Sreepriya Prasannan
29 Jul 2026 · 4 min
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Sreepriya Prasannan
Sreepriya Prasannan
27 Jul 2026 · 14 min
The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint
Industry
The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint
An in-depth, fact-based analysis of water and power consumption across Ireland’s twin industrial pillars, the infrastructure bottlenecks, and the shifting geography of high-tech construction.
Sreepriya Prasannan
Sreepriya Prasannan
27 Jul 2026 · 5 min